Add to ORKGObjective: To examine the relationship between progestin-only contraception and breast cancer, and to make recommendations regarding contraception for the breast cancer survivor. Outcome: Incidence of breast cancer among users of progestin-only contraception. Evidence: PubMed and Medline databases were searched using the terms “breast cancer ” and “progesterone, ” “contraception, ” “depot medroxyprogesterone acetate, ” “Micronor, ” “Mirena, ” and “subdermal implant. ” The citations were limited to the English language. References were searched for other relevant articles. The quality of evidence is described using the classification of the Canadian Task Force on the Periodic Health Exam. Benefits, Harms, and Costs: Providing reliable contra...
Although past studies have shown that oral contraceptives with 50 µg or more of estrogen reduce the ...
Background: Care of the gynecologic cancer survivor extends beyond cancer treatment to encompass pro...
Summarybackground the collaborative group on hormonal factors in breast cancer has brought together ...
Objective: To examine the relationship between progestin-only contraception and breast cancer, and t...
Objective: The efficacy of treatment for many cancers has increased dramatically in recent decades a...
Alfred O Mueck1, Harald Seeger1, Xiangyan Ruan2 1Department of Endocrinology and Menopause, Universi...
Background:Oral contraceptives (OC) are widely used in the United States. Although the relation betw...
BACKGROUND: Fear from increased cancer risk is one of the most significant reasons for low acceptanc...
The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the...
The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the...
OBJECTIVE: To assess the risk of recurrence with hormonal contraceptive use in breast cancer survivo...
The assessment of breast cancer relative morbidity risk in women taking oral contraceptives (OC) or ...
The possibility that the use of hormonal contraceptives may increase the risk of breast cancer has b...
Introduction: Oral contraceptives (OC) have been shown to give a transient increased breast cancer r...
Background:Oral contraceptives (OC) are widely used in the United States. Although the relation betw...
Although past studies have shown that oral contraceptives with 50 µg or more of estrogen reduce the ...
Background: Care of the gynecologic cancer survivor extends beyond cancer treatment to encompass pro...
Summarybackground the collaborative group on hormonal factors in breast cancer has brought together ...
Objective: To examine the relationship between progestin-only contraception and breast cancer, and t...
Objective: The efficacy of treatment for many cancers has increased dramatically in recent decades a...
Alfred O Mueck1, Harald Seeger1, Xiangyan Ruan2 1Department of Endocrinology and Menopause, Universi...
Background:Oral contraceptives (OC) are widely used in the United States. Although the relation betw...
BACKGROUND: Fear from increased cancer risk is one of the most significant reasons for low acceptanc...
The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the...
The Collaborative Group on Hormonal Factors in Breast Cancer has brought together and reanalysed the...
OBJECTIVE: To assess the risk of recurrence with hormonal contraceptive use in breast cancer survivo...
The assessment of breast cancer relative morbidity risk in women taking oral contraceptives (OC) or ...
The possibility that the use of hormonal contraceptives may increase the risk of breast cancer has b...
Introduction: Oral contraceptives (OC) have been shown to give a transient increased breast cancer r...
Background:Oral contraceptives (OC) are widely used in the United States. Although the relation betw...
Although past studies have shown that oral contraceptives with 50 µg or more of estrogen reduce the ...
Background: Care of the gynecologic cancer survivor extends beyond cancer treatment to encompass pro...
Summarybackground the collaborative group on hormonal factors in breast cancer has brought together ...